We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.86B
AUM Growth
-$412M
Cap. Flow
+$88.2M
Cap. Flow %
1.81%
Top 10 Hldgs %
32.54%
Holding
208
New
15
Increased
86
Reduced
85
Closed
22

Top Buys

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$67.9M
2
LTH icon
Life Time Group Holdings
LTH
+$64.3M
3
CHGG icon
Chegg
CHGG
+$42.3M
4
ENVX icon
Enovix
ENVX
+$41.2M
5
EEFT icon
Euronet Worldwide
EEFT
+$30.6M

Top Sells

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$60.1M
2
GTLS
Chart Industries
GTLS
+$52M
3
WK icon
Workiva
WK
+$40M
4
KRNT icon
Kornit Digital
KRNT
+$30.5M
5
RSKD icon
Riskified
RSKD
+$25.7M

Sector Composition

Rank Sector Weight
1 Technology 35.92%
2 Healthcare 18.43%
3 Industrials 16.38%
4 Consumer Discretionary 12.45%
5 Financials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
151
Xencor
XNCR
$1.6B
$4.93M 0.1%
122,835
-4,899
-4% -$186K
AIP icon
152
Arteris
AIP
$1.25B
$4.78M 0.1%
+226,531
New +$5.14M
CTSO icon
153
Cytosorbents Corp
CTSO
$22.7M
$4.63M 0.1%
1,105,607
-48,954
-4% -$275K
PRTA icon
154
Prothena Corp
PRTA
$468M
$4.46M 0.09%
90,179
+44,875
+99% +$2.49M
CERS icon
155
Cerus
CERS
$508M
$4.4M 0.09%
645,565
-1,147,690
-64% -$7.73M
BMRA icon
156
Biomerica
BMRA
$5.04M
$4.29M 0.09%
137,822
+8,902
+7% +$343K
SKIN icon
157
SkinHealth Systems
SKIN
$82.9M
$4.18M 0.09%
173,224
-6,787
-4% -$175K
CRVL icon
158
CorVel
CRVL
$3.15B
$4.13M 0.09%
59,541
-30,825
-34% -$1.94M
AMN icon
159
AMN Healthcare
AMN
$1.42B
$3.99M 0.08%
+32,604
New +$3.62M
TTD icon
160
Trade Desk
TTD
$6.29B
$3.99M 0.08%
43,503
-30,607
-41% -$2.68M
APLS
161
DELISTED
Apellis Pharmaceuticals
APLS
$3.95M 0.08%
+83,601
New +$3.29M
MPWR icon
162
Monolithic Power Systems
MPWR
$67.9B
$3.79M 0.08%
7,685
-1,658
-18% -$856K
PLRX icon
163
Pliant Therapeutics
PLRX
$64.4M
$3.69M 0.08%
+273,185
New +$4.34M
CRSP icon
164
CRISPR Therapeutics
CRSP
$5.17B
$3.6M 0.07%
47,541
+2,211
+5% +$193K
RVNC
165
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.53M 0.07%
216,497
+88,258
+69% +$1.47M
CYBR
166
DELISTED
CyberArk
CYBR
$3.51M 0.07%
20,247
+755
+4% +$132K
SWIR
167
DELISTED
Sierra Wireless
SWIR
$3.37M 0.07%
191,508
-63,668
-25% -$1.07M
PRTK
168
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.37M 0.07%
749,740
-71,914
-9% -$341K
EDIT icon
169
Editas Medicine
EDIT
$432M
$3.32M 0.07%
125,183
+1,516
+1% +$52.2K
PTLO icon
170
Portillo's
PTLO
$325M
$3.27M 0.07%
+87,053
New +$3.49M
MGNX icon
171
MacroGenics
MGNX
$259M
$3.2M 0.07%
199,541
-31,517
-14% -$593K
OLK
172
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$3.09M 0.06%
170,021
-15,809
-9% -$390K
EVBG
173
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.88M 0.06%
+42,813
New +$5.18M
VERI icon
174
Veritone
VERI
$134M
$2.88M 0.06%
128,203
+36,253
+39% +$931K
DMTK
175
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.32M 0.05%
147,095
+51,271
+54% +$1.23M
5 6
7
8 9

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Granahan Investment Management held 208 positions worth $4.86B, down 7.8% from $5.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management's Q4 2021 filing shows 15 new, 86 increased, 85 reduced and 22 closed positions. Its largest new stake was Stratasys: 2,436,279 shares worth $59.7M. The largest sale was Enphase Energy, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q4 2021 buy was Stratasys: 2,436,279 shares worth $59.7M.
  • Granahan Investment Management added most to Chegg in Q4 2021, an estimated $42.3M increase.
  • Granahan Investment Management's biggest Q4 2021 reduction was Enphase Energy, cutting an estimated $60.1M.
  • Granahan Investment Management fully exited Riskified in Q4 2021, selling an estimated $25.7M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $4.86B portfolio in Q4 2021.
  • Granahan Investment Management opened 15 new positions and closed 22 in Q4 2021.
  • Granahan Investment Management's portfolio value fell 7.8% quarter-over-quarter to $4.86B.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.